1. Home
  2. COEP vs HSON Comparison

COEP vs HSON Comparison

Compare COEP & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • HSON
  • Stock Information
  • Founded
  • COEP 2017
  • HSON 1999
  • Country
  • COEP United States
  • HSON United States
  • Employees
  • COEP N/A
  • HSON N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • HSON Professional Services
  • Sector
  • COEP Health Care
  • HSON Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • HSON Nasdaq
  • Market Cap
  • COEP 32.4M
  • HSON 32.2M
  • IPO Year
  • COEP N/A
  • HSON N/A
  • Fundamental
  • Price
  • COEP $10.52
  • HSON $11.15
  • Analyst Decision
  • COEP
  • HSON
  • Analyst Count
  • COEP 0
  • HSON 0
  • Target Price
  • COEP N/A
  • HSON N/A
  • AVG Volume (30 Days)
  • COEP 109.2K
  • HSON 2.5K
  • Earning Date
  • COEP 03-25-2025
  • HSON 03-13-2025
  • Dividend Yield
  • COEP N/A
  • HSON N/A
  • EPS Growth
  • COEP N/A
  • HSON N/A
  • EPS
  • COEP N/A
  • HSON N/A
  • Revenue
  • COEP N/A
  • HSON $140,427,000.00
  • Revenue This Year
  • COEP N/A
  • HSON N/A
  • Revenue Next Year
  • COEP N/A
  • HSON $8.83
  • P/E Ratio
  • COEP N/A
  • HSON N/A
  • Revenue Growth
  • COEP N/A
  • HSON N/A
  • 52 Week Low
  • COEP $2.31
  • HSON $11.15
  • 52 Week High
  • COEP $13.70
  • HSON $19.70
  • Technical
  • Relative Strength Index (RSI)
  • COEP 48.65
  • HSON 24.77
  • Support Level
  • COEP $9.27
  • HSON $11.41
  • Resistance Level
  • COEP $12.95
  • HSON $11.78
  • Average True Range (ATR)
  • COEP 1.59
  • HSON 0.27
  • MACD
  • COEP -0.33
  • HSON -0.09
  • Stochastic Oscillator
  • COEP 38.56
  • HSON 0.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management, and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: